#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Vincent Lepreux Email
Investment Principal - Debiopharm Innovation Fund . Debiopharm
Lausanne,
Locationv**************@debiopharm.com
Primary EmailHow to contact Vincent Lepreux
Join and see Vincent's contact info for free!v**************@debiopharm.com
GROWJO
The Free Company & People Database
Current Roles
Debiopharm
Get all of our best features!
About
Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners to maximize patient access across the globe. Debiopharm International SA focuses on the development of prescription drugs that target unmet medical needs. The company in-licenses and develops promising drug candidates. The products are commercialized by pharmaceutical out-licensing partners to give access to the largest number of patients worldwide. Debiopharm completed the development and licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat® If you have interesting molecules and seek a competent and committed partner to develop them, please contact us.Debiopharm Address
Chemin Messidor 5-7Lausanne, null